An observational study in Robotic, Laparoscopic and Colon Cancer, sponsored by Taiyuan Li. Completed. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2024-06-12.
Sponsored by Taiyuan Li · Observational
The goal of this observational study is to evaluate the short-term outcomes and long-term outcomes of robot-assisted right colon group for cancer compared to laparoscopic-assisted right colon group. This is a large sample study based on ten years of clinical data. The main question it aims to answer is: What are the advantages of da Vinci robot right hemicolectomy compared to laparoscopic right hemicolectomy, and is there a difference in long-term efficacy between the two methods.
Colorectal cancer (CRC) is highly prevalent worldwide. In China, CRC ranks high among the population of men and women with cancer. The incidence and mortality rates of CRC are rising quickly in developing countries, and it is the fourth most deadly cancer in the world. In particular, the right colon cancer (RCC) is continuously growing in China, and the early symptoms of RCC are not typical. one of the most useful ways for RCC is surgical is a surgical operation. Along with the development of minimally invasive surgery, the use of laparoscopy for colon cancer is widely accepted and has become one symbolic surgical technology. Studies have demonstrated that laparoscopic colonic surgery is related to reduced pain after operation, shorter rehabilitation time, shorter length of hospital stay, reduced the time of ileus after surgery, and reduced surgical site infection.
Nevertheless, laparoscopic surgery also has its shortcoming, including a limited range of motion, slow learning and growth, and physiological tremor cannot be eliminated.The emergence of robots has broken the inherent disadvantage of laparoscopy. It has achieved similar or better results in previous studies. Based on these advantages, robotic surgery has received much attention from the surgeons. With the first robotic surgery in the field of colon cancer was reported in 2002, there are some studies proved the safety and feasibility by using robot,However, most studies with small sample sizes and with cases at a relatively early stage.
Therefore, the purpose of this study is to compare the short-term and long-term outcomes between RARC and LARC in the treatment of right colon cancer in our center.
1,432 studies on the registry are indexed under Colonic Neoplasms; 357 are open to participants now.
This study's enrollment of 1,879 is above the median of 280 across 349 observational studies indexed under Colonic Neoplasms.
Browse Colonic Neoplasms studies →Taiyuan Li is the lead sponsor of 5 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
The consecutive cases of robotic-assisted or laparoscopic-assisted right colectomy between December 2014 and March 2024. All cases derived from the First Affiliated Hospital of Nanchang University.
Exclusion Criteria:
Robot assisted radical surgery for right colon cancer
Device: Da Vinci Robot Surgical System
Laparoscopic assisted radical surgery for right colon cancer
Device: Da Vinci Robot Surgical System
Performing surgery on right colon cancer patients using the da Vinci robotic surgical system or laparoscopic surgical system
Also known as: Laparoscopic surgical system
overall survival
months
Time frame: 5 years after surgery
disease-free survival
months
Time frame: 5 years after surgery
the rate of postoperative complications
rate
Time frame: 1 months after surgery
operative time
minutes
Time frame: Intraoperative
estimation of blood loss
milliliters
Time frame: Intraoperative
number of retrieved lymph nodes
numbers
Time frame: Intraoperative
days after postoperative hospital stay
days
Time frame: 1 months after surgery
time to first exhaust
hours
Time frame: 1 weeks after surgery
time to liquid diet
hours
Time frame: 1 weeks after surgery
the rate of intracorporeal anastomosis
rate
Time frame: 1 months after surgery
No study locations are listed for this record.
Documents are hosted by the registry — open the source record to download them.
Plan to share: Undecided — Access to the database can be obtained from the corresponding author on reasonable request.
This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Taiyuan Li